E Jacky
Overview
Explore the profile of E Jacky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
113
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guldenschuh I, Schiess R, Jacky E, Burger J, Landis T
Behav Neurol
. 2014 Feb;
6(3):165-6.
PMID: 24487115
Although hyperviscosity syndrome may lead to cerebral hypoxia and produce some degree of dementia, this condition is rarely recognized. We report a patient in whom moderate dementia was the only...
2.
Andreisek G, Jacky E, Weishaupt D
Rofo
. 2004 Sep;
176(9):1329-31.
PMID: 15346271
No abstract available.
3.
Jermann M, Jost L, Taverna C, Jacky E, Honegger H, Betticher D, et al.
Ann Oncol
. 2004 Mar;
15(3):511-6.
PMID: 14998858
Background: Relapsed or refractory diffuse large B-cell and mantle-cell lymphoma have a poor prognosis. The EPOCH regimen and rituximab monotherapy have demonstrated activity as salvage therapies. Because of their non-overlapping...
4.
Fehr T, Jacky E, Bachli E
Ann Hematol
. 2003 Mar;
82(3):193-6.
PMID: 12634957
Low-dose methotrexate (MTX) is used as disease-modifying therapy in severe rheumatoid arthritis and as maintenance treatment in patients with complete remission of acute lymphoblastic leukemia (ALL). It is generally well...
5.
Trojan A, Jacky E, Follath F, Dummer R
Swiss Med Wkly
. 2003 Feb;
133(1-2):22-3.
PMID: 12596092
No abstract available.
6.
Morant R, Schmitz S, Bernhard J, Thurlimann B, Borner M, Wernli M, et al.
Eur J Cancer
. 2002 Jul;
38(12):1626-32.
PMID: 12142053
The purpose of this study was to evaluate the efficacy of vinorelbine treatment in terms of prostate-specific antigen (PSA) response and clinical benefit (decrease of pain or analgesic score for...
7.
Tscherry G, Jacky E, Jost L, Stahel R
Oncology
. 2000 Sep;
59(2):110-7.
PMID: 10971168
The prognosis of germ cell tumors treated with chemotherapy depends on the presence of nonseminomatous tumor, clinical parameters based on the tumor volume and site, as well as on the...
8.
Morant R, Bernhard J, Maibach R, Borner M, Fey M, Thurlimann B, et al.
Ann Oncol
. 2000 Apr;
11(2):183-8.
PMID: 10761753
Background: In a phase II trial, 43 patients with hormone-refractory prostate cancer were treated with gemcitabine at a dose of 1,200 mg/m2 over 2 hours (later decreased to 1,000 mg/m2...
9.
Stahel R, Jost L, Kroner T, Dommann-Scherrer C, Maurer R, Glanzmann C, et al.
Br J Haematol
. 1999 Apr;
104(4):763-9.
PMID: 10192438
Several centres reported a favourable outcome after high-dose chemotherapy with autologous progenitor cell transplantation in selected patients with high-risk large cell non-Hodgkin's lymphoma in first remission. Based on these observations,...
10.
HEUBERGER W, Berardi S, Jacky E, Pey P, Krahenbuhl S
Eur J Clin Pharmacol
. 1998 Dec;
54(7):503-8.
PMID: 9832290
Objective: To study the effect of cisplatin on plasma concentrations and urinary excretion of carnitine in ten patients with different malignancies treated with chemotherapy. Methods: Carnitine concentrations were determined using...